ロード中...
Trastuzumab Beyond Progression in Retrospective Analyses: An Issue of Equal Opportunities
Results of the Hermine study of trastuzumab beyond progression in breast cancer patients, published by Extra and colleagues in The Oncologist, are re-examined and an alternative explanation for the dismal postprogression survival time of patients stopping therapy is presented.
保存先:
| 主要な著者: | , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
AlphaMed Press
2011
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3228112/ https://ncbi.nlm.nih.gov/pubmed/21393343 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2010-0329 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|